Impact of a Delayed Diagnosis of Vulvar Cancer and Its Association with HIV Infection: A 4-year Review at a Tertiary Hospital in KwaZulu-Natal, South Africa

Overview

Journal South Afr J HIV Med

Specialty Infectious Diseases

Date 2021 Oct 25

PMID 34691768

Citations 1

Authors

Ramakhosana S Hlapane

Thandekile L Khumalo

Bongumusa S Makhathini

Jagidesa Moodley

Affiliations

Soon will be listed here.

Abstract

Background: Vulvar cancer is becoming more common in young women owing to the increased prevalence of co-infection with human papillomavirus and HIV.

Objectives: The aim of this study was to determine the impact of the time interval from the diagnosis of vulvar cancer at the referring institution to the tertiary hospital and to evaluate the impact of HIV infection in the study population.

Method: This was a retrospective descriptive chart review.

Results: A total of 86 cases of vulvar cancer were analysed. The mean age was 48.2 ± 12.5. Sixty (69.8%) patients were under 50 years of age and eight (9.3%) under 30 years. The interval from the onset of symptoms to the diagnosis of cancer was > 12 months in 63 (73.3%) patients. Eighty-one (94.8%) had had symptoms treated multiple times prior to diagnosis. Seventy (81.4%) were referred to the tertiary institution within 3 months of the diagnosis of cancer. Seventy (81.4%) had concomitant HIV infection. Of those with CD4 counts of > 200 cells/mm, 61.7% had early-stage vulvar cancer, while 38.3% had late-stage disease ( = 0.048). There was no association between the viral load and the Federation of Gynaecology and Obstetrics stage ( = 0.401). The primary treatment was surgery in 50%.

Conclusion: Although the study was retrospective, we found that vulvar cancer was prevalent in younger patients with HIV infection. Higher CD4 counts were associated with early-stage disease. Early sampling of suspicious lesions can ensure early diagnosis of vulvar cancer and the initiation of therapeutic interventions, particularly in HIV-infected patients.

Citing Articles

Update on Prevalence of Pain in Patients with Cancer 2022: A Systematic Literature Review and Meta-Analysis.

Snijders R, Brom L, Theunissen M, van den Beuken-van Everdingen M Cancers (Basel). 2023; 15(3).

PMID: 36765547 PMC: 9913127. DOI: 10.3390/cancers15030591.

References

Butt J, Botha M . Vulvar cancer is not a disease of the elderly: Treatment and outcome at a tertiary referral centre in South Africa. S Afr Med J. 2017; 107(11):1000-1004. DOI: 10.7196/SAMJ.2017.v107i11.12497. View

Conley L, Ellerbrock T, Bush T, Chiasson M, Sawo D, Wright T . HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study. Lancet. 2002; 359(9301):108-13. DOI: 10.1016/S0140-6736(02)07368-3. View

Alkatout I, Schubert M, Garbrecht N, Weigel M, Jonat W, Mundhenke C . Vulvar cancer: epidemiology, clinical presentation, and management options. Int J Womens Health. 2015; 7:305-13. PMC: 4374790. DOI: 10.2147/IJWH.S68979. View

Brinton L, Thistle J, Liao L, Trabert B . Epidemiology of vulvar neoplasia in the NIH-AARP Study. Gynecol Oncol. 2017; 145(2):298-304. PMC: 5629039. DOI: 10.1016/j.ygyno.2017.02.030. View

KRUPP P, Bohm J, Lee F, COLLINS J . Current status of the treatment of epidermoid cancer of the vulva. Cancer. 1976; 38(1 SUPPL):587-95. DOI: 10.1002/1097-0142(197607)38:1<587::aid-cncr2820380183>3.0.co;2-d. View

Lanneau G, Argenta P, Lanneau M, Riffenburgh R, Gold M, McMeekin D . Vulvar cancer in young women: demographic features and outcome evaluation. Am J Obstet Gynecol. 2009; 200(6):645.e1-5. DOI: 10.1016/j.ajog.2009.01.014. View

Barlow E, Kang Y, Hacker N, Canfell K . Changing Trends in Vulvar Cancer Incidence and Mortality Rates in Australia Since 1982. Int J Gynecol Cancer. 2015; 25(9):1683-9. DOI: 10.1097/IGC.0000000000000547. View

Leonard B, Kridelka F, Delbecque K, Goffin F, Demoulin S, Doyen J . A clinical and pathological overview of vulvar condyloma acuminatum, intraepithelial neoplasia, and squamous cell carcinoma. Biomed Res Int. 2014; 2014:480573. PMC: 3956289. DOI: 10.1155/2014/480573. View

Ebrahim S, Mndende X, Kharsany A, Mbulawa Z, Naranbhai V, Frohlich J . High Burden of Human Papillomavirus (HPV) Infection among Young Women in KwaZulu-Natal, South Africa. PLoS One. 2016; 11(1):e0146603. PMC: 4718633. DOI: 10.1371/journal.pone.0146603. View

10.

Bateman C . HIV training of traditional healers limps along. S Afr Med J. 2004; 94(10):804-6. View

11.

Hacker N, Barlow E . Staging for vulvar cancer. Best Pract Res Clin Obstet Gynaecol. 2015; 29(6):802-11. DOI: 10.1016/j.bpobgyn.2015.01.004. View

12.

Minkoff H, Zhong Y, Burk R, Palefsky J, Xue X, Watts D . Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Infect Dis. 2010; 201(5):681-90. PMC: 2818607. DOI: 10.1086/650467. View

13.

Rogers L, Cuello M . Cancer of the vulva. Int J Gynaecol Obstet. 2018; 143 Suppl 2:4-13. DOI: 10.1002/ijgo.12609. View

14.

Kang Y, Smith M, Barlow E, Coffey K, Hacker N, Canfell K . Vulvar cancer in high-income countries: Increasing burden of disease. Int J Cancer. 2017; 141(11):2174-2186. DOI: 10.1002/ijc.30900. View

15.

Mbulawa Z, Marais D, Johnson L, Coetzee D, Williamson A . Impact of human immunodeficiency virus on the natural history of human papillomavirus genital infection in South African men and women. J Infect Dis. 2012; 206(1):15-27. DOI: 10.1093/infdis/jis299. View

16.

Liu G, Sharma M, Tan N, Barnabas R . HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer. AIDS. 2018; 32(6):795-808. PMC: 5854529. DOI: 10.1097/QAD.0000000000001765. View